Palmer SC, Tendal B, Mustafa RA et al (2021) Sodiumglucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Negli ultimi anni, per, si verificato un punto di svolta nel trattamento farmacologico dellobesit: grazie a risultati incoraggianti negli studi clinici, nel 2021 stato approvato dallEMA un analogo del GLP-1 , chiamato semaglutide
10.3892/etm.2019.7347 107 WangL.LiP.TangZ.YanX.FengB
The risk of photolysis Even though B12 is very stable when dry, it is also extremely light-sensitive in liquid form
A provider can help determine if your symptoms are a standard reaction to the medication or if they indicate an underlying issue that needs attention
doi:10.1111/dom.12591 Suran M